Aimovig and Live birth - a phase IV clinical study of FDA data

Summary:

Live birth is reported as a side effect among people who take Aimovig (erenumab-aooe), especially for people who are 40-49 old, also take Leflunomide, and have Migraine.

The phase IV clinical study analyzes which people have Live birth when taking Aimovig. It is created by eHealthMe based on reports of 49,844 people who have side effects when taking Aimovig from the FDA, and is updated regularly.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

What is Live birth?

Live birth is found to be associated with 478 drugs and 510 conditions by eHealthMe. Check the latest studies of Live birth.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

49,844 people reported to have side effects when taking Aimovig.
Among them, 98 people (0.2%) have Live birth.

Among these 98 people:

What is the age of people who have Live birth when taking Aimovig? *

What are other drugs people take besides Aimovig? *

What are other side effects people have besides Live birth? *

Hair Loss: 88 people, 89.80%
Joint Pain: 87 people, 88.78%
Glossodynia (a burning or painful sensation in the tongue): 86 people, 87.76%
Abdominal Discomfort: 83 people, 84.69%
High Blood Pressure: 83 people, 84.69%
Anti-Cyclic Citrullinated Peptide Antibody Positive: 83 people, 84.69%
High Blood Cholesterol: 83 people, 84.69%
Drug Intolerance (drug sensitivity): 81 people, 82.65%
Hand Deformity: 80 people, 81.63%
General Physical Health Deterioration (weak health status): 80 people, 81.63%

What are the existing conditions these people have? *

Migraine (headache): 97 people, 98.98%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 92 people, 93.88%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 79 people, 80.61%
Psoriasis (immune-mediated disease that affects the skin): 64 people, 65.31%
Arthropathy: 6 people, 6.12%
Indigestion: 5 people, 5.10%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 3.06%
Abdominal Discomfort: 3 people, 3.06%
Synovitis (inflammation of the synovial membrane): 2 people, 2.04%
Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 2 people, 2.04%

* Approximation only. Some reports may have incomplete information.

Do you take Aimovig and have Live birth?

- Check whether Live birth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aimovig:

Aimovig (49,930 reports)

Live birth treatments and more:

Live birth (8,041 reports)

Browse all side effects of Aimovig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Live birth:

Live birth (478 drugs)

Browse all the conditions that are associated with Live birth:

Live birth (510 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on erenumab-aooe (the active ingredients of Aimovig) and Aimovig (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.